Patent question, page-7

howdy Joe, we are getting a bit ahead of ourselves but.

consider the following.........

All the big miners of the world own the mines but they engage mining services companies

to operate the mines, worley parsons. monadelphous, thiess to name a few are operators.

It appears Immutep are heading in that direction with the big pharma except they have

a slice of the action with "EFTI"which gives them a bit more skin in the game.

Large pharma have identified extensive trials are a drain on their cashflows and more

and more of them are trimming their research trial pipelines down via culling we have

often read about lately.....

My opinion on the future of Immutep, I suspect pending AIPAC ph2 results will determine

the speed of evolvement.......I think it will be on the market by end 2019FY. with an

agreement to continue PH3 trials with compensation by the buyer.....

I also suspect that the funds received from selloff will set Immutep up for the future...

Off course that all depends on AIPAC hitting the mark and a lot more ifs and buts,

but for what it's worth thats the direction I feel the company is heading in....